Document is current
Any future updates will be listed below
-
Authors
Amiri, Hamed
Javid, Hossein
Einafshar, Elham
Ghavidel, Farideh
Rajabian, Arezoo
Hashemy, Seyed Isaac https://orcid.org/0000-0002-1323-5250
Hosseini, Hossein https://orcid.org/0000-0003-4859-7291
-
Funding
Funding for this research was provided by:
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
Mashhad University of Medical Sciences, Mashhad, Iran (401034)
- License Information
-
More Information
Article History
Accepted: 20 February 2024
First Online: 27 February 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: This declaration confirms that the usage of PC-3 prostate cancer cells in the study has been conducted in accordance with the relevant ethical principles, guidelines, and regulations.
